The adverse effects of octreotide on wound healing in rats

American Surgeon

Volumn 63, Issue 5, 1997, Pages 446-449

  Waddell, Brad E ^a   Calton Jr , William C ^b   Steinberg, Sidney R ^c   Martindale, Robert G ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c US Aeromedical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE SODIUM SUCCINATE; OCTREOTIDE; TELAZOL; TILETAMINE; ZOLAZEPAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENDOCRINE TUMOR; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER REGENERATION; MUSCLE STRENGTH; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL WOUND; TISSUE REGENERATION; TUMOR GROWTH; WOUND HEALING;

ANIMALS; HORMONES; MALE; OCTREOTIDE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; WOUND HEALING;

EID: 0030978617     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Reichlin S. Somatostatin (first of two parts). N Engl J Med 1983;309:1495-501.
2. Reichlin S. Somatostatin (second of two parts). N Engl J Med 1983;309:1556-63.
3. Lucey MR, Yamada T. Biochemistry and physiology of gastrointestinal somatostatin. Dig Dis Sci 1989;34:5S-13S.
4. Grosman I, Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am J Gastroenterol 1990;85:1061-72.
5. Hurst RD, Modlin IM. The therapeutic role of octreotide in the management of surgical disorders. Am J Surg 1991;162: 499-507.
6. Burroughs AK, McCormick PA, Hughes MD, et al. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990;99:1388-95.
7. Nubiola P, Badia JM, Martinez-Rodenas F, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg 1989;210:56-8.
8. Rosen GH. Somatostatin and its analogs in the short bowel syndrome. Nutr Clin Pract 1992;7:81-5.
9. Geer RJ, Richards WO, O'Dorisio TM, et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990;212:678-87.
10. Gray JL, Debas HT, Mulvihill SJ. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Arch Surg 1991;126:1231-6.
11. Gullo L, Barbara L. Treatment of pancreatic pseudocysts with octreotide. Lancet 1991;338:540-1.
12. Mozell EJ, Weltering EA, O'Dorisio TM. Non-endocrine applications of somatostatin and octreotide acetate: Facts and flights of fancy. Dis Month 1991;37:751-848.
13. Evers BM, Parekh D, Townsend CM, Thompson JC. Somatostatin and analogues in the treatment of cancer. Ann Surg 1991;213:190-8.
14. Bass BL, Fischer BA, Richardson C, Harmon JW. Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats. Am J Surg 1991;161:107-12.
15. Thompson JS, Nguyen BT, Harty RF. Somatostatin analogue inhibits intestinal regeneration. Arch Surg 1993;128:385-9.
16. Pruthi RS, Farouk M, Tsai WH, et al. The effect of octreotide on hepatic regeneration in rats. Surgery 1993;113:84-9.
17. Konturek SJ, Dembinski A, Warzecha Z, et al. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988;94:1300-7.
18. Ehrlich HP, Hunt TK. Effects of cortisone and vitamin A on wound healing. Ann Surg 1968;167:324-8.
19. Dostal OH, Gamelli RL. The differential effect of corticosteroids on wound disruption strength in mice. Arch Surg 1990; 125:636-40.